Publication | Open Access

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial

Hematological MalignancyOncologyMarrow TransplantationTransplantationStem Cell TransplantationImmunologyHematologyClinical TrialsMultiple MyelomaBlood TransplantationMedicineCell TransplantationHealth Sciences